Medicaid rebates 1991
Executive Summary
Glaxo reports paying Medicaid rebates of $60 mil. during second half of calendar 1991. If the company's payments in the first six months were at a similar level, it may well have rebated over $100 mil. to the state and federal governments in 1991. The total rebates for 1991 have been estimated in the $570 mil. range. Glaxo may be paying around 20% of the rebates. By comparison, Bristol-Myers Squibb paid rebates of $55 mil. in 1991; Pfizer $44 mil., Merck approximately $30-$35 mil.